Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert-L Bell

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Eplasty|September 21, 2012
Prognostication for body contouring surgery after bariatric surgeryDevinder Singh, Antonio J V Forte, Hamid R Zahiri, et al.
The Journal of Biological Chemistry|December 21, 2006
DeltaF508 mutation results in impaired gastric acid secretionShafik M Sidani, Philipp Kirchhoff, Thenral Socrates, et al.
Journal of Clinical Pharmacology|March 13, 2014
Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjectsStephen L Lowe, Conrad J Wong, Jennifer Witcher, et al.
The International Journal of Neuropsychopharmacology|February 1, 2015
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and humanLinda M Rorick-Kehn, Jennifer W Witcher, Stephen L Lowe, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Eplasty|September 21, 2012
Prognostication for body contouring surgery after bariatric surgeryDevinder Singh, Antonio J V Forte, Hamid R Zahiri, et al.
The Journal of Biological Chemistry|December 21, 2006
DeltaF508 mutation results in impaired gastric acid secretionShafik M Sidani, Philipp Kirchhoff, Thenral Socrates, et al.
Journal of Clinical Pharmacology|March 13, 2014
Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjectsStephen L Lowe, Conrad J Wong, Jennifer Witcher, et al.
The International Journal of Neuropsychopharmacology|February 1, 2015
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and humanLinda M Rorick-Kehn, Jennifer W Witcher, Stephen L Lowe, et al.
Pageof 6